Clinical Trial Update: Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions [NA]

View source ↗

Summary

This document reports the completion of a bioequivalence study of dronedarone hydrochloride tablets in healthy fasting subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dronedarone hydrochloride tablets (dronedarone hydrochloride)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Atrial Fibrillation (AF) | NA | Status: COMPLETED